Fentanyl is being pulled from shelves in Spain — and the reason may surprise you

Fentanyl in Spain: data and controversies over its dispensing in pharmacies. Is it as common as claimed? An analysis of a debate dividing professionals.

English · Original discussion in Spanish · Published

Fentanyl in Spain: the opioid dividing pharmacists and patients

In a Spanish pharmacy, for every box of fentanyl dispensed, ten boxes of other narcotics are handed out. Yet public and media perception places it as a threat comparable to the American crisis. The Spanish reality is more complex: fentanyl coexists with oxycodone and morphine in an opioid market where the line between medical use and abuse is blurry.

The dispensing paradox

Data from observers in pharmacies reveal a gap between perception and practice. While some claim fentanyl is the most dispensed opioid and cite up to 8-10 different brands available, others place it as a minority drug compared to oxycodone and morphine. One pharmacist noted that for every box of fentanyl, ten boxes of other narcotics are sold, and that out of every ten patients in the pharmacy, seven buy barbiturates and four buy major opioids. The disparity of criteria suggests that prescribing patterns vary significantly by region and hospital protocol.

From medical use to the illegal market: the Spanish vs. American context

In the United States, the illegal fentanyl epidemic is the consequence of the massive overprescription of opioids promoted by laboratories such as Sackler. In Spain, however, illegal fentanyl has barely any presence. Distribution is concentrated in medical prescriptions, and abuse cases are more linked to the diversion of patches from elderly or terminally ill patients. Even so, the debate is open: is the Spanish health system too lax in prescribing these drugs? Opinions are divided between those who see sufficient control and those who warn of a possible rise in addiction.

Theories about the withdrawal of fentanyl

A minority current holds that fentanyl is being deliberately withdrawn from the market to promote drugs that generate more violence and social control. However, there is no evidence of a widespread withdrawal. Dispensing data indicate that, while fentanyl is still being prescribed, its use has stabilized or even decreased in favor of alternatives such as oxycodone/naloxone, which has a lower abuse potential. The lack of transparency in official statistics fuels these theories.



The question underlying the debate is how much we really know about the flow of opioids in our pharmacies. The answer, as often happens, is that the available data are insufficient to settle the discussion.

Related debates in the forum

Also available in: Deutsch

Summary of a discussion on Burbuja.info - Foro de economía, actualidad y política., translated from Spanish and reviewed before publication. Read the full discussion (57 replies).

More summaries

All summaries in English →

-
Back